
naturalX Health Ventures
AI Verified
Germany
Venture Capital
Berlin Ostbahnhof, Mitteltunnel, Friedrichshain, Friedrichshain-Kreuzberg, Berlin, 10243, Germany
2022
Criteria | Requirements | Match |
---|---|---|
Regions | North America, Northern Europe, Western Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Series A, Seed, Series B |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
naturalX Health Ventures represents a significant €100 million investment vehicle dedicated to transforming the consumer health landscape through strategic funding of innovative startups. Operating primarily across European markets, the fund identifies and supports companies that demonstrate potential to revolutionize healthcare delivery, patient experiences, and wellness solutions. With a clear vision for the future of health technology and services, naturalX positions itself at the intersection of traditional healthcare and emerging consumer-focused innovations.
The fund's investment strategy centers predominantly on Series-A stage companies, while maintaining flexibility to engage with promising late Seed ventures and select Series-B opportunities that align with their vision. This strategic approach allows naturalX to support companies at critical growth inflection points, providing not just capital but also industry expertise and connections when startups are establishing market validation and scaling their operations. Their portfolio reflects a diverse range of health innovations spanning digital therapeutics, personalized medicine, preventative health technologies, and consumer wellness platforms.
As a portfolio fund backed by Schwabe Group, naturalX benefits from the extensive industry knowledge and global reach of one of the world's foremost authorities in plant-based pharmaceuticals. This partnership provides portfolio companies with unique advantages, including potential access to Schwabe's extensive research capabilities, regulatory expertise, and established distribution networks across international markets. The connection to Schwabe Group also reflects naturalX's commitment to supporting scientifically-sound health innovations that can demonstrate measurable outcomes and clinical validity.
Beyond financial investment, naturalX offers portfolio companies valuable guidance through the complex regulatory landscapes of European healthcare markets and assistance with international expansion strategies. The fund's team brings together professionals with diverse backgrounds spanning pharmaceutical development, health technology, consumer marketing, and venture finance. This multidisciplinary expertise enables naturalX to provide comprehensive support to founders navigating the unique challenges of scaling health-focused businesses while maintaining compliance with evolving healthcare regulations and standards across different European jurisdictions.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
naturalX Health Ventures maintains its global headquarters in Germany, serving as the strategic center for its operations. The company's primary corporate offices are located at Berlin Ostbahnhof, Mitteltunnel, Friedrichshain, Friedrichshain-Kreuzberg, Berlin, 10243, Germany.
naturalX Health Ventures focuses its investment activities on companies operating in the following stages: Series A, Seed, Series B. naturalX Health Ventures provides strategic capital and expertise to support promising businesses at these critical phases of development.
naturalX Health Ventures maintains a strategic global investment presence, actively seeking opportunities across the following key regions: North America, Northern Europe, Western Europe.
naturalX Health Ventures was established in 2022, marking the beginning of its journey as an investment firm.
naturalX Health Ventures is the following type of investment firm: Venture Capital. The organization provides capital and strategic support to entrepreneurs and growing companies.